SCN1A, present in 9.8% of cases, was primarily associated with DS, aligning with prior studies indicating frequencies ranging from 8%–15% in epilepsy cohorts (Zuberi et al., 2011; Olson et al., 2017; Yang et al., 2019). Here, SCN1A is linked to epilepsy.